Washington, D.C., April 5, 2024—Viscadia, a global consulting firm renowned for empowering life sciences companies with clarity and confidence through forecasting, proudly announces its participation in the Pharmaceutical Management Science Association Conference taking place in Denver, CO from May 5-8. Viscadia is a Gold Sponsor of the conference.

On May 6, a poster entitled, “Risk Modeling in Early-Stage Forecasts – A Machine Learning Approach” will be on display during the Welcome Reception and will be available for viewing throughout the conference. The poster was developed by Anindya Roy, a Principal with Viscadia. Anindya has 15 years of experience in forecasting and analytics for the life sciences industry.

Commenting on this poster presentation, Anindya remarked, “Understanding risks and the range of potential outcomes is crucial for decision-making predicated on early-stage forecasts. The primary source of uncertainty in these forecasts is clinical uncertainty. Risk varies significantly by therapeutic categories, and the risk landscape at the product levels has also changed significantly over time. A novel, machine learning based approach that incorporates clinical risk objectively into these early-stage forecasts will go a long way towards making them more effective and actionable”.

Viscadia will also host a booth (Booth 106-108) on the exhibit floor. Satish Kauta, Founder & CEO of Viscadia, commented, “We are delighted to have a strong presence at the conference as we enter the next phase of growth for Viscadia. We look forward to welcoming colleagues to our booth and engaging stakeholders in the life sciences forecasting ecosystem”.

Viscadia is also a co-sponsor of the Women in Analytics Luncheon on Tuesday, May 7. The company looks forward to celebrating women who are forecasting specialists and invites all who are interested in a career in forecasting to attend the luncheon and connect with the Viscadia team.